Ascendis Pharma A/S Profit Margin

Ascendis Pharma A/S's profit margin stands at 71.69% as of June 2026. That compares with -55.25% in the prior-year period — up 229.7% year over year. That is above the Healthcare sector average of 21.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Ascendis Pharma A/S reported 71.69% in profit margin versus -55.25% a year earlier — a 229.7% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Ascendis Pharma A/S sits higher the Healthcare benchmark (21.34%) with a profit margin of 71.69%. That is roughly 236.0% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 71.69% for Ascendis Pharma A/S means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Ascendis Pharma A/S's profit margin evolved across reporting periods, while the comparison chart places ASND next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.